Human Tumor Xenograft Models for Preclinical Assessment of Anticancer Drug Development
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
2234-2753
- Extent
-
Online-Ressource
- Language
-
Englisch
- Notes
-
online resource.
- Bibliographic citation
-
Human Tumor Xenograft Models for Preclinical Assessment of Anticancer Drug Development ; volume:30 ; number:1 ; day:30 ; month:12 ; year:2014 ; pages:1-5 ; date:3.2014
Toxicological research ; 30, Heft 1 (30.12.2014), 1-5, 3.2014
- Creator
-
Jung, Joohee
- Contributor
-
SpringerLink (Online service)
- DOI
-
10.5487/TR.2014.30.1.001
- URN
-
urn:nbn:de:101:1-2021090420150088069339
- Rights
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
15.08.2025, 7:20 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Jung, Joohee
- SpringerLink (Online service)
Other Objects (12)
Cannabinoids as anticancer drugs: current status of preclinical research
Zebrafish Patient-Derived Xenograft Model as a Preclinical Platform for Uveal Melanoma Drug Discovery
Molecular and preclinical evaluation of patient-derived orthotopic xenograft models of pediatric brain tumors
Relevance of tumor models for anticancer drug development
Microarray analysis in clinical oncology: pre-clinical optimization using needle core biopsies from xenograft tumors
DRAP: a toolbox for drug response analysis and visualization tailored for preclinical drug testing on patient-derived xenograft models
Sex-dependent liver cancer xenograft models for predicting clinical data in the evaluation of anticancer drugs
New anticancer drugs
A Microvascularized Tumor-mimetic Platform for Assessing Anti-cancer Drug Efficacy
Anticancer Water‐Soluble Organoruthenium Complexes: Synthesis and Preclinical Evaluation
PDXGEM: patient-derived tumor xenograft-based gene expression model for predicting clinical response to anticancer therapy in cancer patients
Anti-tumoral efficacy of therapeutic human anti-KIR antibody (Lirilumab/BMS-986015/IPH2102) in a preclinical xenograft tumor model
Cannabinoids as anticancer drugs: current status of preclinical research
Zebrafish Patient-Derived Xenograft Model as a Preclinical Platform for Uveal Melanoma Drug Discovery
Molecular and preclinical evaluation of patient-derived orthotopic xenograft models of pediatric brain tumors
Relevance of tumor models for anticancer drug development
Microarray analysis in clinical oncology: pre-clinical optimization using needle core biopsies from xenograft tumors
DRAP: a toolbox for drug response analysis and visualization tailored for preclinical drug testing on patient-derived xenograft models
Sex-dependent liver cancer xenograft models for predicting clinical data in the evaluation of anticancer drugs
New anticancer drugs
A Microvascularized Tumor-mimetic Platform for Assessing Anti-cancer Drug Efficacy
Anticancer Water‐Soluble Organoruthenium Complexes: Synthesis and Preclinical Evaluation
PDXGEM: patient-derived tumor xenograft-based gene expression model for predicting clinical response to anticancer therapy in cancer patients
Anti-tumoral efficacy of therapeutic human anti-KIR antibody (Lirilumab/BMS-986015/IPH2102) in a preclinical xenograft tumor model
Cannabinoids as anticancer drugs: current status of preclinical research
Zebrafish Patient-Derived Xenograft Model as a Preclinical Platform for Uveal Melanoma Drug Discovery
Molecular and preclinical evaluation of patient-derived orthotopic xenograft models of pediatric brain tumors
Relevance of tumor models for anticancer drug development
Microarray analysis in clinical oncology: pre-clinical optimization using needle core biopsies from xenograft tumors
DRAP: a toolbox for drug response analysis and visualization tailored for preclinical drug testing on patient-derived xenograft models
Sex-dependent liver cancer xenograft models for predicting clinical data in the evaluation of anticancer drugs
New anticancer drugs
A Microvascularized Tumor-mimetic Platform for Assessing Anti-cancer Drug Efficacy
Anticancer Water‐Soluble Organoruthenium Complexes: Synthesis and Preclinical Evaluation
PDXGEM: patient-derived tumor xenograft-based gene expression model for predicting clinical response to anticancer therapy in cancer patients